HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $60 price target.
May 16, 2024 | 5:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Precision BioSciences and maintained a $60 price target, indicating strong confidence in the company's future performance.
The reiteration of a Buy rating and a high price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100